Neovasc Inc.

Recent News

  • Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 11, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter HighlightsGenerated revenue of $514,000 in the quarter and $1.97 million for the full year as Reducer implants rebounded after declining due to the COVID-19 pandemic.In December, announced the completion of the first Neovasc Reducer™ ("Reducer") implants in France.Completed a registered...

    2021-03-11 5:05 PM ET
  • Neovasc to Report Fourth Quarter and Fiscal Year 2020 Results on March 11, 2021

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 4, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) will report results for the fourth quarter and fiscal year ended December 31, 2020 after the market close on Thursday, March 11, 2021. Neovasc President and Chief Executive Officer Fred Colen and Chief Financial Officer Chris Clark will host a conference call to review the Company's results at 4:30 pm EST.Interested parties may access the conference call by dialing (877) 407-9208...

    2021-03-04 10:00 AM ET
  • Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 3, 2021) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 2021 H.C. Wainwright Global Life Sciences Conference that is scheduled to take place March 9-10, 2021. A recorded presentation by Bill Little, Neovasc's Chief Operating Officer, will be available on the Conference website starting at 7:00 am EST on March 9. Company management will also be scheduling one-on-one meetings with investors;...

    2021-03-03 5:30 PM ET
  • Neovasc Comments on Clinical Cardiology Journal Publication

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 2, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the journal Clinical Cardiology has published an article entitled, "Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study."The article, authored by Maayan Konigstein, M.D., Tel Aviv Medical Center and Sackler School of Medicine, Tel Aviv University, Israel describes the long-term outcomes in 99 patients treated with the Neovasc Reducer™ ("Reducer")...

    2021-03-02 10:00 AM ET
  • Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 24, 2021) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum market value requirement set forth in the rules for continued listing on the Nasdaq Capital Market (the "Listing Rules").Neovasc received a letter from the Nasdaq in December 2020 notifying the Company that it...

    2021-02-24 5:05 PM ET
  • Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference

    Vancouver, British Columbia--(Newsfile Corp. - February 17, 2021) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021. Fred Colen, Neovasc's President and Chief Executive Officer, will present on Friday, February 26, 2021 at 1:00 pm EST.A link to the live webcast of the presentation will be available online from the investor relations section...

    2021-02-17 10:00 AM ET
  • Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - February 12, 2021) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) announced today that it has closed its previously announced sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules for aggregate gross proceeds to the Company of approximately US$72 million, before deducting placement agent's fees and estimated...

    2021-02-12 4:53 PM ET
  • Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - February 10, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules for aggregate gross proceeds to the Company of approximately US$72 million,...

    2021-02-10 8:38 AM ET